EXAS vs WSBCO
EXACT Sciences Corporation (EXAS) versus WesBanco, Inc. (WSBCO) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
WesBanco, Inc. (WSBCO) is a banks - regional company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
WSBCO does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. WSBCO currently screens at market cap $0.
Not investment advice. Open the EXAS and WSBCO stock pages for the full models.
Not investment advice.